VN1R110P

Across TCGA pan-cancer cohorts, VN1R110P RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of VN1R110P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where VN1R110P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VN1R110P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

HNSC, KIRP, and LUSC are the cancer types where VN1R110P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VN1R110P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Female	All	+0.157	<.001	12	view →
KIRP	All	II,III,IV	+0.131	.006	6	view →
LUSC	Male	All	+0.257	<.001	5	view →
LUAD	All	All	+0.061	.008	4	view →
LIHC	All	All	+0.107	.004	3	view →
BRCA	Female	All	+0.032	.028	3	view →
UCEC	All	All	+0.122	.019	2	view →
THCA	All	All	−0.024	.027	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

VN1R110P–HNSC

Open the HNSC breakdown →